Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences
September 10 2020 - 6:05AM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the
“Company”) today announced that members of the senior management
team will participate in fireside chats during the following
upcoming virtual investor conferences:
- H.C. Wainwright & Co. 22nd Annual Global Investment
Conference on September 14, 2020 at 10:30 a.m. EDT. Register
here
- Cantor Virtual Global Healthcare Conference on September 16,
2020 at 4:00 p.m. EDT. Register here
- Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
on September 23, 2020 at 1:40 p.m. ET. Register here
In order to participate in the audio webcast, interested parties
can register and access the live webcast under "News/Events”
through the “Investors” section of the Aurinia corporate website at
www.auriniapharma.com. A replay of the webcast will be available on
Aurinia’s website.
ABOUT AURINIA
Aurinia Pharmaceuticals is a late-stage clinical
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are impacted
by serious diseases with a high unmet medical need. The Company is
currently seeking FDA approval of voclosporin for the potential
treatment of lupus nephritis and evaluating voclosporin ophthalmic
solution (VOS) in a Phase 2/3 study for the treatment of dry eye
syndrome. The Company’s head office is in Victoria, British
Columbia, its U.S. commercial hub in Rockville, Maryland, and
focuses its development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200910005304/en/
Investor & Corporate Contact: Glenn Schulman, PharmD,
MPH SVP, Corporate Communications & IR
gschulman@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Sep 2023 to Sep 2024